Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.

Front Immunol · 2023 · PMC10331425 · PMID 37435088

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

We observed a decreasing trend in the M2 macrophage fraction post-C/T for most Late Recurrence patients, though this was not statistically significant (adjusted P = 0.17) ( Figure 12A ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.